KRAS G12D

Quiénes somos

• febrero 29, 2024

  A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation

• febrero 5, 2024

  ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (AMPLIFY-201)

• 31 de agosto de 2023

  A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors